ABIOMED Inc (NASDAQ:ABMD)
| 328.46 Delayed Data As of Jul 23 |  +4.92 / +1.52%Today’s Change | 242.73 Today|||52-Week Range 387.40 | +1.31% Year-to-Date |
Latest ABMD News | Press Releases
No recent news for ABIOMED Inc.
Today’s Trading
| Previous close | 323.54 |
| Today’s open | 325.56 |
| Day’s range | 323.74 - 328.75 |
| Volume | 5,189 |
| Average volume (3 months) | 260,630 |
| Market cap | $14.4B |
Data as of 3:59pm ET, 07/23/2021
Growth & Valuation
| Earnings growth (last year) | +11.19% |
| Earnings growth (this year) | -12.32% |
| Earnings growth (next 5 years) | +12.82% |
| Revenue growth (last year) | +0.79% |
| P/E ratio | 66.5 |
| Price/Sales | 17.18 |
| Price/Book | 10.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PODDInsulet Corp | +5.03 | +1.85% |
| TFXTeleflex Inc | +4.73 | +1.20% |
| PENPenumbra Inc | -0.76 | -0.28% |
| NEGGNewegg Commerce Inc | -1.46 | -5.65% |
Data as of 4:06pm ET, 07/23/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $1.06 |
| Annual revenue (last year) | $847.5M |
| Annual profit (last year) | $225.5M |
| Net profit margin | 26.61% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |
Forecasts
